Equities

Genflow Biosciences PLC

GENF:LSE

Genflow Biosciences PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2.15
  • Today's Change0.00 / 0.00%
  • Shares traded37.60k
  • 1 Year change23.92%
  • Beta--
Data delayed at least 20 minutes, as of Sep 27 2024 15:21 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at Genflow Biosciences PLC fell by 1.67m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 1.66m for operations while cash used for investing totalled 2.44k.
Cash flow per share-0.0056
Price/Cash flow per share--
Book value per share0.0025
Tangible book value per share0.0025
More ▼

Balance sheet in GBPView more

Genflow Biosciences PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio3.09
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.